MedPath
NMPA Approval

Diprophylline Injection

国药准字H20253499

March 4, 2025

Drug Information

二羟丙茶碱注射液

注射剂

2ml:0.3g

化学药品

March 4, 2025

Company Information

Applicant Company

安徽省合肥市高新区红枫路10号中成药生产研发楼

Manufacturing Company

江苏省沭阳经济技术开发区宁波路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

二羟丙茶碱注射液 - NMPA 批准文号 | MedPath